The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Molecular Viral Pathogenesis
Volume 15 - 2025 |
doi: 10.3389/fcimb.2025.1536156
This article is part of the Research Topic Detection and Drug Treatment of Emerging Viral Diseases View all 4 articles
SHASI-ML: A Machine Learning-Based approach for immunogenicity prediction in Salmonella vaccine development
Provisionally accepted- Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy
Accurate prediction of immunogenic proteins is critical for vaccine development and understanding host-pathogen interactions. This study presents SHASI-ML, a machine learning-based framework designed to predict immunogenic proteins in bacterial pathogens, specifically focused on Salmonella species. From a published dataset of immunogenic and non-immunogenic proteins, three groups of features were extracted from sequences and used to train and test the model, obtaining an outstanding ability to identify bacterial immunogens. SHASI-ML identified 292 immunogenic proteins, demonstrating an 89.3% detection rate for validated immunogens. The method achieved precision and specificity of 89.3% and 91.2%, respectively, with superior recall and F1-scores compared to existing approaches. Additionally, the importance of each group of features in the prediction was performed. These findings validate SHASI-ML as an efficient tool for prioritizing immunogenic candidates, reducing the time and cost of vaccine research. The results obtained in this work could be used to guide and optimize the research and industrialization of Salmonella vaccines.
Keywords: Salmonella, artificial intelligence, machine learning, Vaccines, immunogenicitiy
Received: 28 Nov 2024; Accepted: 22 Jan 2025.
Copyright: © 2025 Spiga, Visibelli, Pettini, Roncaglia and Santucci. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ottavia Spiga, Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.